167 related articles for article (PubMed ID: 16190801)
1. Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series.
Pathak S; Johns ES; Kowatch RA
J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):696-702. PubMed ID: 16190801
[TBL] [Abstract][Full Text] [Related]
2. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
[TBL] [Abstract][Full Text] [Related]
3. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine augmentation in depressed patients with partial response to antidepressants.
Olver JS; Ignatiadis S; Maruff P; Burrows GD; Norman TR
Hum Psychopharmacol; 2008 Dec; 23(8):653-60. PubMed ID: 18816504
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: an open-label, pilot study.
Anderson IM; Sarsfield A; Haddad PM
J Affect Disord; 2009 Sep; 117(1-2):116-9. PubMed ID: 19171384
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.
Denys D; de Geus F; van Megen HJ; Westenberg HG
J Clin Psychiatry; 2004 Aug; 65(8):1040-8. PubMed ID: 15323587
[TBL] [Abstract][Full Text] [Related]
7. Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.
Cutler AJ; Montgomery SA; Feifel D; Lazarus A; Aström M; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):526-39. PubMed ID: 19358790
[TBL] [Abstract][Full Text] [Related]
8. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
McIntyre A; Gendron A; McIntyre A
Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.
Mohr N; Vythilingum B; Emsley RA; Stein DJ
Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study.
Bogan AM; Koran LM; Chuong HW; Vapnik T; Bystritsky A
J Clin Psychiatry; 2005 Jan; 66(1):73-9. PubMed ID: 15669891
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
13. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
[TBL] [Abstract][Full Text] [Related]
14. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
Ann Clin Psychiatry; 2013 Nov; 25(4):E7-22. PubMed ID: 24199224
[TBL] [Abstract][Full Text] [Related]
15. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
Ann Clin Psychiatry; 2014 Feb; 26(1):3-18. PubMed ID: 24660224
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
Maneeton N; Maneeton B; Srisurapanont M; Martin SD
BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L
Postgrad Med; 2010 Jul; 122(4):39-48. PubMed ID: 20675970
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms.
Devarajan S; Ali J; Dursun SM
Psychopharmacology (Berl); 2006 Apr; 185(3):402-3. PubMed ID: 16538471
[No Abstract] [Full Text] [Related]
20. Quetiapine-induced weight gain and escitalopram.
Holzer L; Paiva G; Halfon O
Am J Psychiatry; 2005 Jan; 162(1):192-3. PubMed ID: 15625223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
